Sonoma Pharmaceuticals, Inc. filed its 10-K on Jun 21, 2023 for the period ending Mar 31, 2023. In this report its auditor, Frazier & Deeter, LLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.25 USD | +66.67% | +61.39% | +38.58% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.58% | 3.9M | |
+32.36% | 694B | |
+30.77% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.77% | 239B | |
+9.13% | 209B | |
-3.97% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- SNOA Stock
- News Sonoma Pharmaceuticals, Inc.
- Sonoma Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt